Legionella Testing Market Size, Share and Analysis Report, 2024

The global Legionella Testing Market is expected to grow at a considerable rate over the forecast period owing to the advancements and automation in the immunodiagnostic market such as the introduction of advanced ELISA antibodies for the prevention of legionnaires diseases in the market. The rapidly rising awareness about legionella based diseases and the increase in demand for advanced immunodiagnostic techniques is a direct consequence of rapidly increasing incidences of mild flu and pneumonia like diseases through legionella bacteria. Since legionella bacteria requires the presence of iron and cysteine to grow, it is traditionally detected by culture on buffered charcoal yeast extract. This process takes 4 to 5 days for detecting the legionella bacteria. The advanced immunological techniques such as polymerase chain reaction and rapid immunological assays are efficient to detect the legionella bacteria in few minutes. These techniques are commonly used to establish the presence of species of Legionella bacteria in the sample. Some of the other drivers for the growth of the global legionella testing market include the entry of new players, new emerging economies such as China and India and increase in the funding for healthcare facilities by the government in many regions. There are about 40 different species of legionella bacteria out of which 18 species are infectious. Among all these species, the legionella pneumophilla bacterium can cause most of the diseases. Many hospitals have started various tests such as legionella urinary antigen test for the initial detection of legionella based diseases. This is the factor expected to further fuel the legionella testing market over the forecast period.

Request Sample Copy for Legionella Testing Market Report

The legionella testing market has been divided on the basis of antibiotics used for the treatment of legionella infections into rifampin, azithromycin, ketolides, quinolones and macrolides. It is expected that Azithromycin drug will grow at the fastest rate throughout the forecast period owing to its efficiency to treat legionella based diseases. Azithromycin drug is mainly used for treating this infection in children and adults. The increasing incidences of legionella based diseases in children and adults is also a factor driving the Azithromycin drug segment in the market. Apart, certain flouroquinolones such as moxifloxacin and levofloxacin are also considered as the most efficient drugs for legionella based diseases. There are several diagnostic tests which are available commercially in the market for initial detection of Legionella bacteria in the body such as sputum or lung tissue test, urine antigen test, chest X-ray and blood test. There are various end users of legionella testing drugs which include hospitals, commercial or private labs, physician offices and public health labs.

Major regions estimated for the legionella testing market are North America, Europe, Asia Pacific and RoW. As of 2013, North America dominated the market attributing the largest share in terms of revenue. This large share can be accounted for by the increasing number of patients suffering from legionella based diseases, the presence of large number of market players and government initiatives such as various public health labs across the region. Owing to the new emerging economies such as Germany and U.K. and rising awareness about legionella based diseases in the Europe region, it is expected that this region will show lucrative growth in the global legionella testing market over the forecast period.

The key participants in the legionella testing market include Roche Diagnostics, Beckman Coulter, Bio Rad, Novartis Diagnostics, Life Technology, Becton Dickinson, Abott laboratories, Eiken Chemical, ID Biomedical, Thermo Fischer, Takara Bio, Kreatech, Gen Probe, Enzo Biochem and SeraCare. The market leaders in the global legionella testing market are involved in continuous efforts for the development of innovative methodologies of testing which would increase the efficiency and accuracy of test results while providing the smooth processing of larger samples simultaneously. This companies are also entering into strategic collaborations and expansions to extend their global patient base.

Browse Detailed TOC @ https://www.hexaresearch.com/research-report/legionella-testing-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Medical Tourism Market - Industry Size, Share and Segmentation, 2024

The Medical Tourism Market is defined by patients travelling abroad to seek surgical or medical assistance for quality treatment available overseas. The market is at a growth stage and is expected to grow further over the forecast period buoyed by factors such as quality of healthcare offered at optimal cost, expert healthcare practitioners, and customized approach in providing end-to-end services including support in obtaining a medical visa to arranging patients’ stay. In addition, prevailing cost of medical services in patients’ home-country, availability of advanced healthcare treatment facility, and legal restrictions on a few medical practices such as fertility processes in home country are adding to the growth of medical tourism market. In addition, increase in campaign and marketing of medical facilities to endorse medical tourism and presence of international health insurance is expected to boost the market over the forecast period. Presence of cashless facility and wide number of hospital under insurance coverage are also expected to provide opportunities for market growth. Medical tourism and international accreditation continue to play a vital role in patient inflow into destination countries boosting medical tourism. The number of accredited facilities is rising year-on-year giving international exposure to hospitals, indirectly linking medical tourism successfully.  

Request for Sample Copy of the Report @ Medical Tourism Market

Improving healthcare infrastructure, presence of favorable government policies, and presence of quality healthcare service at lower price is propelling the market in the Asia Pacific region. Among the various countries in Asia Pacific, India is increasingly becoming a medical tourism hub as the country offers cost advantage, has quality hospitals and skilled doctors, and favorable medical visa policies. For instance, India’s e-medical visa facility permits three medical visits to patients in the country. The country also offers medical visa for follow up treatment. Dental tourism and cosmetic surgeries are among the leading sectors for medical tourism in India. Major inflow of patients in India are from countries such as UAE, Middle East, Africa, Bangladesh, Sri Lanka, Afghanistan, Uzbekistan, Kuwait, and Mauritius. Besides India, Thailand secures prime spot in medical tourism market. Malaysia is another prominent destination amongst medically sophisticated infrastructure led nations. Economically affordable treatments lay the road for Malaysia to be one of the most forward-looking nations in medical tourism market.

Technology leverage to bring in innovation in healthcare has also added to the growth of the market. Technology usage including cloud computing and web 2.0 has spurred growth in the market. Cloud computing is largely being leveraged for keeping and sharing electronic medical records. Leveraging cloud computing, electronic medical record (EMR) can be made available universally to healthcare service providers. All healthcare tourism service providers and healthcare practitioners can access the same medical record on a real-time basis. Besides bringing efficiency in the process, EMR decreases extra diagnosis and medication errors and brings efficacy in healthcare systems.  

Some of the popular hospital chains active in the market include Apollo Hospitals, Asian Heart Institute and Research Centre, Fortis Healthcare, Aditya Birla Memorial Hospital, NTT Medical Center Tokyo, KPJ Healthcare Berhad, Seoul National University Hospital, Raffles Medical Group, Prince Court Medical Centre, Barbados Fertility Centre, Bangkok Hospital Medical Center, Min-Sheng General Hospital are the leading healthcare tourism provider.

Browse Detailed TOC @ https://www.hexaresearch.com/research-report/medical-tourism-market

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office P

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Diagnostic Imaging Market - US to Hold Largest Share

The global Diagnostic Imaging Market is projected to witness substantial growth in the coming years owing to rising demand for minimally invasive treatment. Diagnostic imaging is an advanced medical technique to capture clear images of organs and internal structures of the patient’s body. These images are used by healthcare professionals to diagnose and monitor diseases and injuries in patients. Diagnostic imaging enables early diagnosis of chronic diseases, which can increase the chances of successful treatment.

Growing need for advanced diagnostic techniques to study medical conditions in the best possible manner can augment market growth. Medical problems like broken bones, cardiac abnormalities, gastrointestinal issues, and cancer are likely to impel demand for advanced imaging technologies for effective diagnosis and treatment. Clear and detailed images can help healthcare professionals to make accurate and effective medical decisions. This, in turn, can propel demand for technologically advanced medical devices in healthcare facilities. Moreover, supportive government initiatives to develop healthcare infrastructure across the globe can stimulate growth of the market. Rising demand for portable imaging devices in remote areas to improve healthcare facilities and provide better medical treatment can augment market expansion in the coming years.

Request for Sample Copy Report for Diagnostic Imaging Market by Type and Application

High cost of machinery and its installation can hamper growth of the market. However, R&D activities by manufacturing companies to develop technologically advanced medical devices can create lucrative opportunities for the market. For instance, OmniVision Technologies, Inc. in collaboration with Lighthouse Imaging, introduced a new platform that allows medical device manufacturers to integrate stereoscopic 3D imaging into endoscopes. The platform incorporates an image signal processor and two CMOS image sensors from OmniVision, and camera control unit and a light control board for LED illumination from Lighthouse.

The market can be segmented on the basis of product type and application. Based on product type, the market can be categorized into X-ray, computed tomography (CT) scanners, and magnetic resonance imaging (MRI) systems. In terms of application, the market can be classified into cardiovascular and thoracic, neuro and spine, orthopedics and musculoskeletal, obstetrics, and breast health.

North America is likely to witness significant growth in the coming years owing to growing elderly population. The United States is expected to hold the largest share in the market than other developed countries. Rising demand for advanced diagnostic services owing to increasing cases of chronic diseases among elderly population can impel regional market growth. Supportive reimbursement policies and technological developments in imaging modalities by manufacturing companies can drive the market in the coming years. For instance, GE Healthcare launched its new ultrasound system named Versana Essential. The system offers high image quality and help healthcare professionals during diagnosis. Doctors can use it to view kidney vessels, thyroid vasculature, and assess blood flow through the carotid, aorta, and other vessels.

Europe is estimated to witness remarkable market growth owing to significant advancements in in the brain imaging sector and stroke services. Increasing use of teleconsulting and teleradiology in the healthcare sector can impel regional market expansion. Advent of telemedicine in Germany can propel demand for advanced machines to view, access, and share radiographic images or diagnostic reports. Countries like France, United Kingdom, and Russia are also likely to contribute significantly to regional growth. Launch of innovative products by manufacturers can gain traction among healthcare providers. For instance, Philips introduced its new mobile C-arm imaging platform named Zenition. The platform can provide live image guidance to healthcare professionals during surgeries. Advanced features like position memory and BodySmart software can allow the device to capture the images fast and consistently. In addition, MetalSmart software can automatically improve image quality in terms of brightness and contrast.

Asia Pacific is likely to bode well in the coming years owing to growing ageing population and increasing incidence of chronic diseases. Growth of the medical tourism in developing countries like India, Japan, and China owing to advanced healthcare infrastructure can augment regional growth. Supportive government policies and medical grants to execute R&D activities in the healthcare sector can drive the market in the coming years.

Some of the leading companies operating in the diagnostic imaging market are Siemens Healthcare, GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, and Toshiba Medical Systems Corporation.

Browse TOC of the Report @ https://www.hexaresearch.com/research-report/diagnostic-imaging-market

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com

Point of Care (POC) Diagnostics Market Size, Share and Analysis Report

The global Point of Care Diagnostics Market is driven by technological improvements and introduction of sophisticated medical solutions. A host of healthcare establishments are gradually taking to point of care tests and diagnostics solutions for greater efficiency. Growing popularity of EMR (electronic medical record) and PACS (picture archiving and communication systems) has a positive impact on market demand.

Other industry drivers are governmental support, surging healthcare investments, growing geriatric population, and widespread adoption of home based POC devices. When medical diagnostics tests are carried out at the place of patient care, it is known as bedside testing or POCT (point-of-care-testing). New product development is a vital factor that may contribute significantly to market growth during the forecast period (2012 to 2020).

Browse Details of Report @ https://www.hexaresearch.com/research-report/point-of-care-diagnostics-industry

Products, end users, and regions are the parameters based on which the global point of care (POC) diagnostics industry is categorized. As per products, the segments are blood gas/electrolytes, fertility, cardiac markers, OTC & rapid diagnostic tests, infectious diseases, coagulation, drug abuse testing, hospital glucose testing, decentralized clinical chemistry, hematology, and urinalysis. Products also include primary care systems, such as HbA1c tests and lipid profiling. Hospital glucose testing holds the highest market share.

Factors that propel this segment are high incidence of diabetes and the growing necessity for glucose analysis on a regular basis.

The OTC & rapid diagnostic tests market may expand robustly over the forecast period because of the “self diagnosis” trend. People nowadays are highly aware of the importance of early disease diagnosis for on-time & instant disease treatment. Based on end users, the global industry is divided into laboratories, hospitals, clinics, assisted living healthcare facilities, homes, and others. Hospitals & clinics generate highest revenues in the overall market. Diagnostic tests are mostly conducted in clinics and in hospitals. As a result, most of these healthcare centers have begun expanding their POC diagnostic facilities.

Geographically, the worldwide Point Of Care Diagnostics Market is categorized into Asia Pacific, Europe, North America, and Rest of the World (RoW). North America is the largest regional industry. High degree of patient awareness, encouraging government initiatives, and substantial investments in medical infrastructure are prominent regional drivers. It is however, expected that Asia Pacific will register the highest growth rate over the forecast period. This attributes to improvements in healthcare infrastructure in emerging countries, such as India and China.

Companies operating in the global Point Of Care Diagnostics Market continuously strive towards capturing higher market shares. They invest robustly in R&D and product innovations. Prominent market competitors are Trinity Biotech PLC, Danaher Corporation, Siemens Healthcare, Roche Diagnostics, and Becton Dickinson and Company.

In September 2016, Novartis launched the Niji^TM System and Total IgE Test, a POC diagnostic tool. By using just a droplet or two of finer stick blood, this device delivers Immunoglobulin E (IgE) levels in a matter of twelve minutes. This test caters to immediate in-office diagnosis of allergies associated with IgE levels. The availability of such tests in the offices of healthcare providers leads to reduced time for consultation, diagnosis, prognosis, and disease treatment. This in turn leads to better patient outcomes.

Get Sample Copy of this Report @ Point of Care (POC) Diagnostics Market

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Immunoassay Market is Predicted to Exhibit Robust Growth in Coming Years

The global Immunoassay Market is anticipated to witness strong growth in the years to come due to rising incidence of chronic and infectious diseases. Rapid globalization has resulted in the transfer of several types of viruses, pathogens, and bacteria. Growing cases of hospital acquired infections, along with unhealthy sanitation practices in daily life, are also responsible for the spread of infections. In addition, rising occurrence of diseases, including Zika, Ebola, and other contagious pathogens, is expected to support market growth in the years to come.

Rapid expansion of the biotechnology and biopharmaceutical sectors is anticipated to drive the market. Immunoassays offer accurate results regardless of small samples than traditional tests. They find widespread applications in therapeutic drug monitoring, disease diagnosis, clinical pharmacokinetics, and bioequivalence in drug discovery and pharmaceuticals.

Technological advancements in immunoassay instruments are projected to have a positive impact on market growth. Automated instruments and equipment in laboratories are increasingly replacing manually operated units as they offer advantages, such as quick results, and requirement of less space and labor.

Request Sample Copy @ Immunoassay Market

Development of novel assays for various autoimmune conditions, such as oncology and cardiology, is likely to supplement market growth. Additionally, increasing application in diagnosing drug monitoring tests, infectious diseases, toxicology testing, and discovery of biomarkers is anticipated to increase the demand for immunoassay in the years to come. Rising demand for non-invasive diagnostics methods, analytical testing, and growing need for reagents are also expected to create growth opportunities for the market.

However, complexity in the manufacturing of immunoassays and complex assay procedures can challenge the market. In addition, limit of detection (LOD) for most of the immunoassays is limited, which is expected to restrain market growth in the coming years.

Various technologies employed by immunoassays comprise enzyme-linked immunosorbent assay (ELISA), western blotting, rapid tests, immuno-PCR, and enzyme-linked immunospot (ELISPOT). ELISA is likely to expand significantly in the coming years due to extensive use of immunoassay tests in infectious diseases, cancer, and therapeutic drug level monitoring. Furthermore, these tests use various products and services, such as analyzers, reagents and kits, and software. Reagents and kits hold a prominent share in the market due to their repeat purchase. Additionally, growing adoption of immunoassay tests due to rising incidence of chronic and infectious diseases can boost the segment’s growth in the years to come.

North America is the dominant region in the market due to presence of established healthcare infrastructure. High prevalence of chronic diseases, increasing applications of immunoassay methods in cancer research, and growing adoption of low cost and compact instruments in clinical diagnostics and research laboratories are likely to boost regional growth. The U.S. is a key contributor to regional market growth owing to presence of established healthcare facility, well-defined regulatory framework, and existence of major players.

Asia Pacific is projected to witness rapid growth in the years to come. Japan is one of the key contributors to regional market growth. This could be attributed to strong technological growth and high adoption of immunoassays for the detection and measurement of specific proteins or antigen-antibodies in varied applications. Emerging economies, such as India and China, are also expected to contribute significantly to the growth due to development and production of new vaccines, drugs, and biologics. Additionally, increasing number of diagnostic laboratories, and rising investments by the government in the pharmaceutical and biotechnology sectors can boost regional growth. High investment by the local and international players is also anticipated to create growth opportunities for the market in the region. China occupies a key share in the market owing to adoption of automated laboratory systems.

Some of the key participants operating in the immunoassay market are Abbott Laboratories, bioMerieux, Agilent Technologies, Sysmex Corporation, and Thermo Fisher Scientific.

Thermo Fisher Scientific, in collaboration with Achaogen Inc., introduced a new diagnostic immunoassay to measure the concentration of plazomicin. Plazomicin is a therapeutic antibiotic and aminoglycoside employed for the treatment of patients with complicated urinary tract infections.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com

Durable Medical Equipment Market - Current Trends and Growth Opportunities, 2025

The Global Durable Medical Equipment (DME) Market is projected to witness remarkable growth in the coming years owing to increasing cases of diseases requiring long-term care. Chronic diseases, such as cancer, diabetes, and neurological conditions, are boosting the demand for surgical procedures, which call for a wide range of medical equipment. Such medical tools are expensive owing to high risk associated with complex medical procedures. This has, in turn, fueled the demand for durable medical equipment that can be used for long-term care.

Rising cases of cardiovascular and neurological disorders, and growing need for surgical procedures are anticipated to propel demand for durable medical equipment. Alzheimer, epilepsy, and Parkinson’s disease are the common neurological disorders affecting people across the globe. In addition, increasing prevalence of cancer and chronic conditions, such as diabetes, in geriatric population can impel the product demand. High penetration of home healthcare services can also contribute to market growth. Shifting preference for post-operative recovery at home among patients to avoid infections can stimulate market growth. Moreover, constant technological developments by manufacturing companies can impel market expansion in the coming years.

Get a Sample Copy of this Report @ https://www.hexaresearch.com/research-report/durable-medical-equipment-market

Increasing adoption of minimally invasive surgeries and reduction in the number of beds in public hospitals can hamper market growth. In addition, regulatory approval for the commercialization of specific DME and issues related to reimbursement against the purchase of DME can obstruct growth of the market. However, supportive government initiatives to speed up approvals for manufacturers can create lucrative opportunities for the market.

The market can be segmented on the basis of product type and end users. Based on product type, the market can be categorized into personal mobility devices, bathroom safety devices, monitoring and therapeutic devices and medical furniture. On the basis of end user, the market can be divided into hospitals, ambulatory surgical centers, home care settings, and long-term care centers.

The market in Asia Pacific is anticipated to expand significantly in the coming years owing to high R&D investments by healthcare companies and government. Rising cases of life-threating disorders, such as cancer, can impel regional market growth. Growth of the healthcare sector, coupled with rising per capita expenditure on healthcare, can augment demand for DME in the region. Launch of innovative products by local manufacturing companies can gain traction among consumers. For instance, Roche Diabetes Care India launched a glucometer named Accu-Chek Instant S at an affordable price. The device can show blood sugar reading in less than 4 seconds using a small blood sample. Different color indicators, such as blue, green, and red, can tell users regarding glucose level range. The device can automatically synchronize all blood glucose readings through USB to the Accu-Chek Connect Online Portal.

North America is expected to witness substantial growth in the coming years owing to presence of well-developed healthcare infrastructure. High prevalence of diabetes and cancer can also impel demand for healthcare devices that are durable in nature. Presence of major manufacturing companies offering technologically advanced products can stimulate regional market growth. For instance, Dynarex launched its new products, namely Gloves in a Bag and XeroBurn Burn Gel. These gloves can be arranged easily in any kit and are available in both one and two pair packs. In addition, these gloves are available in one standard size- large, and are non-sterile and powder-free. The balm can be used to relieve the pain of all kinds of burns. It contains Lidocaine that provides quick relief to patients.

Some of the leading companies operating in the durable medical equipment market are Medtronic, Stryker Corporation, Dickinson and Company, Becton, and Sunrise Medical LLC.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States  

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Nootropics Market Size is Predicted to Exhibit Speedy Growth by 2025

The Global Nootropics Market is anticipated to expand with a rapid pace in the years to come on account of modernization and technological advancements. Increasing consumer spending on healthcare and wellness products, and rising awareness regarding benefits of the product can drive the market. Additionally, easy accessibility and cost-effectiveness of the product are expected to boost the sale of the product. Growing trend of cognitive enhancement among healthy people for professional advantage, academic success, personal improvement, athletic performance, and to sustain brain activities during old age is projected to boost the product demand in the years to come.

Growing trend of supplements is anticipated to support market growth in the coming years. High adoption of social media platform to promote the products can have a positive impact on market growth. Increasing adoption of nootropics among students is a key driving factor in the market. The product can enhance the efficiency of brain functions and protect the brain from chemical injuries. Memory enhancing nootropic medications improve learning and memory effect and develop the capability of learned behaviors to resist distraction. Furthermore, continuously growing competition in education and career is increasing the product demand among working professionals.

Browse Details of Report @ https://www.hexaresearch.com/research-report/nootropics-market

Numerous people are preferring supplements and smart drugs to enhance concentration and grasping power, thereby boosting market growth. Moreover, these products are used in the treatment of several cognitive and age-related disorders, such as hyperactivity, Alzheimer's disease, and Parkinson's disease. Various individuals across the world are undergoing depression, and other emotional and mood disorders. Thus, increasing demand for mood enhancers is also projected to stimulate market growth in the years to come.

However, low awareness regarding the product among consumers, lack of organized treatment, and hesitation to visit neurologist or psychiatrist, especially in emerging countries can hamper market growth.

Nootropics find their application in memory enhancement, attention and focus, sleep, anti-aging and longevity, anxiety, recovery, mood and depression, and dream enhancement. Memory enhancement holds a prominent share in terms of revenue. This could be attributed to continuously evolving education system and working environment, which involves workload, and mental and physical pressure. Mood and depression, and attention and focus are likely to emerge as prominent applications in near future due to growth of aging population, which is more vulnerable to dementia.

Detailed Research Insights of this Report

North America is one of the leading consumers of nootropics on account of high consciousness among consumers regarding preventive and cognitive health. Factors, such as presence of established players, large population pool, increasing number of self-directed consumers, and proliferation of distribution channel, are likely to support regional growth in the years to come. Furthermore, ongoing research activities by government and private organizations regarding cognitive enhancers and brain supplements are expected to create several opportunities for the regional market.

Asia Pacific is anticipated to witness the fastest growth in the coming years. Emerging countries, such as India and China, have a history of natural and herbal cognitive medicines, which improve the brain functions. Increasing foreign investment in partnership with regional players is anticipated to have a positive impact on regional market growth. Europe is projected to emerge as one of the promising regions in near future on account of growing geriatric population and increasing number of product launches.

The market in Middle East and Africa is expected to expand owing to increasing number of health-conscious consumers. Presence of new entrants in dietary supplements and nootropics business is also expected to supplement regional growth in the years to come.

Some of the leading companies operating in the nootropics market are Cephalon, Inc.; Accelerated Intelligence, Inc.; Purelife Bioscience Co., Ltd.; AlternaScript LLC.; and Nootrobox Inc.

For instance, Life Kitchen, LLC. introduced Liveli, an integrated system of nootropic supplements. It contains more than seventy vitamins, botanicals, minerals, and nutritional precursors that support brain health.

Category Related Report @ https://healthcareforecastreport.blogspot.com/2018/02/neurostimulation-devices-market.html

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States  

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com